GSK PLC-SPON ADR (GSK) Stock Income Statement
USA - New York Stock Exchange - NYSE:GSK - US37733W2044 - ADR
47.86 USD
-0.16 (-0.33%)
47.67 USD
-0.19 (-0.4%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 32.17B | 31.38B | 30.33B | 29.32B | 24.70B | |||
| Minority Interest Expense | -569.00M | -376.00M | -380.00M | -665.00M | -711.00M | |||
| Cost Of Goods | 8.84B | 8.82B | 8.36B | 8.47B | 8.01B | |||
| Gross Profit | 23.33B | 22.56B | 21.96B | 20.86B | 16.69B | |||
| Operating Expenses | 14.90B | 14.42B | 13.66B | 12.46B | 10.94B | |||
| Research and Development | 6.27B | 6.02B | 5.75B | 5.06B | 4.53B | |||
| Selling, General, and Administrative Expenses | 9.01B | 8.97B | 9.03B | 8.13B | 6.75B | |||
| Operating Income | 8.43B | 8.14B | 8.30B | 8.39B | 5.75B | |||
| Interest Income/Expense | -520.00M | -2.54B | -1.29B | -1.44B | -2.36B | |||
| Other Income/Expense | N/A | 218.00M | -48.00M | -799.00M | 561.00M | |||
| Non Recurring Items | -893.00M | -2.34B | -897.00M | -529.00M | -355.00M | |||
| Income Before Taxes | 7.01B | 3.48B | 6.06B | 5.63B | 3.60B | |||
| Income Tax | 951.00M | 526.00M | 756.00M | 707.00M | 83.00M | |||
| Net Income | 5.49B | 2.58B | 4.93B | 14.96B | 4.38B | |||
| EBITDA | 11.97B | 10.69B | 10.60B | 10.54B | 8.13B | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 2.71 | 1.26 | 2.43 | 7.43 | 2.19 | |||
| Non GAAP EPS | 3.44 | 3.24 | 3.15 | 3.00 | 2.87 | |||
| Statistics | ||||||||
| Gross Profit Margin | 72.52% | 71.90% | 72.42% | 71.13% | 67.58% | |||
| Profit Margin | 17.08% | 8.21% | 16.25% | 51.00% | 17.76% | |||
| Operating Profit Margin | 26.20% | 25.93% | 27.38% | 28.63% | 23.28% | |||
All data in GBP